Merck Free Cash Flow 2010-2024 | MRK

Merck free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Merck annual free cash flow for 2023 was $9.143B, a 37.83% decline from 2022.
  • Merck annual free cash flow for 2022 was $14.707B, a 69.55% increase from 2021.
  • Merck annual free cash flow for 2021 was $8.674B, a 172.08% increase from 2020.

Merck Free Cash Flow 2010-2024 | MRK

  • Merck annual free cash flow for 2023 was $9.143B, a 37.83% decline from 2022.
  • Merck annual free cash flow for 2022 was $14.707B, a 69.55% increase from 2021.
  • Merck annual free cash flow for 2021 was $8.674B, a 172.08% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Bayer (BAYRY)$20.1B
Innoviva (INVA)$1.1B